CN105661486A - Healthcare product for women in menstrual period - Google Patents
Healthcare product for women in menstrual period Download PDFInfo
- Publication number
- CN105661486A CN105661486A CN201610073202.8A CN201610073202A CN105661486A CN 105661486 A CN105661486 A CN 105661486A CN 201610073202 A CN201610073202 A CN 201610073202A CN 105661486 A CN105661486 A CN 105661486A
- Authority
- CN
- China
- Prior art keywords
- parts
- semen
- wulf
- health product
- sojae atricolor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003821 menstrual periods Effects 0.000 title abstract 2
- 240000006162 Chenopodium quinoa Species 0.000 claims abstract description 26
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 25
- 239000002994 raw material Substances 0.000 claims abstract description 20
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 5
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 5
- 210000000582 semen Anatomy 0.000 claims description 67
- 230000036541 health Effects 0.000 claims description 34
- 241000233866 Fungi Species 0.000 claims description 13
- 235000009392 Vitis Nutrition 0.000 claims description 9
- 241000219095 Vitis Species 0.000 claims description 9
- 235000021028 berry Nutrition 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 4
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 4
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 4
- 235000021014 blueberries Nutrition 0.000 claims description 4
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical group CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 claims description 3
- 240000001717 Vaccinium macrocarpon Species 0.000 claims description 3
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 3
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 3
- 235000004634 cranberry Nutrition 0.000 claims description 3
- 150000002333 glycines Chemical class 0.000 claims description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 abstract description 8
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 239000000262 estrogen Substances 0.000 abstract description 5
- 229940011871 estrogen Drugs 0.000 abstract description 5
- 230000029849 luteinization Effects 0.000 abstract description 5
- 230000016087 ovulation Effects 0.000 abstract description 5
- 230000008217 follicular development Effects 0.000 abstract description 3
- 244000068988 Glycine max Species 0.000 abstract description 2
- 235000010469 Glycine max Nutrition 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 230000007661 gastrointestinal function Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 18
- 235000013305 food Nutrition 0.000 description 13
- 230000000694 effects Effects 0.000 description 10
- 210000004696 endometrium Anatomy 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 229920001503 Glucan Polymers 0.000 description 6
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 6
- 210000001672 ovary Anatomy 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 229920002498 Beta-glucan Polymers 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 230000002175 menstrual effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010020710 Hyperphagia Diseases 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000004602 germ cell Anatomy 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 208000022530 polyphagia Diseases 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241001070941 Castanea Species 0.000 description 2
- 235000014036 Castanea Nutrition 0.000 description 2
- 241001107116 Castanospermum australe Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 235000021279 black bean Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000007366 host health Effects 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 2
- 230000001294 luteotrophic effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000011599 ovarian follicle development Effects 0.000 description 2
- 230000027758 ovulation cycle Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000583 progesterone congener Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- -1 starch etc. Chemical compound 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FZWBNHMXJMCXLU-UHFFFAOYSA-N 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC(O)C(O)C(O)C(O)C=O)O1 FZWBNHMXJMCXLU-UHFFFAOYSA-N 0.000 description 1
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 description 1
- VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 241001327634 Agaricus blazei Species 0.000 description 1
- 240000007440 Agaricus campestris Species 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 241001537207 Flammulina Species 0.000 description 1
- MPJKWIXIYCLVCU-UHFFFAOYSA-N Folinic acid Natural products NC1=NC2=C(N(C=O)C(CNc3ccc(cc3)C(=O)NC(CCC(=O)O)CC(=O)O)CN2)C(=O)N1 MPJKWIXIYCLVCU-UHFFFAOYSA-N 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- ZCOLJUOHXJRHDI-FZHKGVQDSA-N Genistein 7-O-glucoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)c1cc(O)c2C(=O)C(c3ccc(O)cc3)=COc2c1 ZCOLJUOHXJRHDI-FZHKGVQDSA-N 0.000 description 1
- CJPNHKPXZYYCME-UHFFFAOYSA-N Genistin Natural products OCC1OC(Oc2ccc(O)c3OC(=CC(=O)c23)c4ccc(O)cc4)C(O)C(O)C1O CJPNHKPXZYYCME-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 240000000588 Hericium erinaceus Species 0.000 description 1
- 235000007328 Hericium erinaceus Nutrition 0.000 description 1
- 208000002682 Hyperkalemia Diseases 0.000 description 1
- 206010021036 Hyponatraemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000976924 Inca Species 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 240000002769 Morchella esculenta Species 0.000 description 1
- 235000002779 Morchella esculenta Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- YCUNGEJJOMKCGZ-UHFFFAOYSA-N Pallidiflorin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC(O)=C2C1=O YCUNGEJJOMKCGZ-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000760198 Russula vinosa Species 0.000 description 1
- 241000272503 Sparassis radicata Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000231230 Suillus bovinus Species 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 240000006794 Volvariella volvacea Species 0.000 description 1
- 235000004501 Volvariella volvacea Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000004246 corpus luteum Anatomy 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000000550 effect on aging Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002357 endometrial effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000008191 folinic acid Nutrition 0.000 description 1
- 239000011672 folinic acid Substances 0.000 description 1
- VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000002503 granulosa cell Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229960001691 leucovorin Drugs 0.000 description 1
- 210000002596 lutein cell Anatomy 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F5/00—Coffee; Coffee substitutes; Preparations thereof
- A23F5/44—Coffee substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A healthcare product for women in the menstrual period is prepared from raw material in parts by weight as follows: 10-20 parts of edible mushrooms, 15-20 parts of nuts, 2-8 parts of soybeans, 5-15 parts of quinoa, 8-12 parts of prebiotics and 1-5 parts of an antioxidant. When taken by the women in the first week of a luteal phase, the healthcare product has the advantages that follicular development can be promoted, estrogen can be supplemented, ovulation can be promoted, the kidney can be strengthened and tonified, the liver can be soothed, vital energy can be regulated, gastrointestinal functions can be coordinated, and bowel movement of the intestinal tract can be promoted.
Description
Technical field
The invention belongs to field of health care products, particularly relate to the health product that a kind of women physiological period is taken.
Background technology
Determining female physiological periodicity be divided into menstrual phase, follicular phase and luteal phase three phases. The women of child-bearing age are left and right every other month, and endometrium occurs once independently to thicken, and the growth of blood vessel hyperplasia, body of gland is secreted and endometrium collapse comes off and with hemorrhage cyclically-varying, this periodicity vaginal haemorrhage or metrorrhagia phenomenon are called menstruation. The method that menstrual cycle calculates is within first day, to count from a upper menstruation, after 28 days, exactly second time menstrual phase starts, but due to the difference of body constitution, age, weather, area and living condition, and menstrual cycle also can difference to some extent, before and after 28 days in the scope of 7 days, all belong to normal range. Follicular phase, this phase to ovary ovulation day only, lasted 10~12 days by ischomenia day last time. Interim at this, the granulosa cell of this phase follicle produces estrogen under the effect of follicule-stimulating hormone (FSH) and lutropin, and under the effect of estrogen, endometrium is bred rapidly, blood vessel hyperplasia, the broadening lengthening of body of gland, but does not secrete. In this end of term, ovary is ovulated. Luteal phase, arriving the previous day of menstrual onset after referring to ovulation, ovary is by the impact of luteotrophic hormone, secretion lutein, maintains the endometrium thickened, in order to germ cell work bed, if without germ cell work bed, endometrium will disintegrate, physiological period with work menstrual onset terminate. The 15th~28 day of physiological period, generally lasts for 14 days, and now in ovary, follicular development is ripe, and ovulation gradually forms corpus luteum. In this end of term, endometrial growth culminates, and plantation and continuation growth for germ cell have prepared condition.
Health care is nursed one's health at present, although have some medicines and food, but the health-care effect to women is not especially desirable about the health of determining female physiological periodicity.
Summary of the invention
In view of this, it is an object of the invention to propose the health product that a kind of women physiological period is taken, it is possible to the feature for determining female physiological periodicity is provided with conditioning targetedly and health care.
In order to some aspects of the embodiment disclosed are had a basic understanding, shown below is simple summary. This summarized section is not extensive overview, neither determine key/critical component or describe the protection domain of these embodiments. Its sole purpose is to present some concepts by simple form, in this, as the preamble of following detailed description.
In some illustrative embodiment, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: edible fungi 10~20 parts;Nut 15~25 parts; Semen sojae atricolor 2~8 parts; Quinoa 5~15 parts; Prebiotics 8~12 parts.
In some illustrative embodiment, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: edible fungi 10~20 parts; Nut 15~25 parts; Semen sojae atricolor 2~8 parts; Quinoa 5~15 parts; Prebiotics 8~12 parts; Antioxidant 1~5 part.
In some illustrative embodiment, described antioxidant is Fructus Citri Limoniae, Semen Vitis viniferae or the certain kind of berries.
In some illustrative embodiment, described edible fungi is Sparassia crispa (Wulf.) Fr.; Described nut is Semen Castaneae; Described Semen sojae atricolor is Semen sojae atricolor.
In some illustrative embodiment, described Sparassia crispa (Wulf.) Fr. is Sparassia crispa (Wulf.) Fr.-H, Sparassia crispa (Wulf.) Fr.-X or Sparassia crispa (Wulf.) Fr.-G; The described certain kind of berries is blue berry or cranberry.
In some illustrative embodiment, the described health product for women physiological period are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 11~13 parts; 18~22 parts of Semen Castaneae; 4~6 parts of Semen sojae atricolor; Quinoa 8~12 parts; Prebiotics 8~12 parts; 1 part of Fructus Citri Limoniae.
In some illustrative embodiment, the described health product for women physiological period are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 11~13 parts; 18~22 parts of Semen Castaneae; 4~6 parts of Semen sojae atricolor; Quinoa 8~12 parts; Prebiotics 8~12 parts; Semen Vitis viniferae 1~2 part.
In some illustrative embodiment, the parts by weight of described Sparassia crispa (Wulf.) Fr. are 12 parts; The parts by weight of described Semen Castaneae are 20 parts; The parts by weight of described Quinoa are 10 parts; The parts by weight of described prebiotics are 10 parts.
In some illustrative embodiment, each raw material is processed to powdery and makes capsule, tablet or electuary.
Preferably, described health product women took at pmgravid first week.
For above-mentioned and relevant purpose, one or more embodiments include the feature that will be explained in below and be particularly pointed out in the claims. Description below describes some illustrative aspects and some modes in the utilizable various modes of principle of only each embodiment of its instruction in detail. Other benefit and novel features will become apparent upon along with detailed description below, and the disclosed embodiments are to include all these aspects and theirs is equivalent.
Detailed description of the invention
It is described below and specific embodiments of the present invention are shown fully, to enable those skilled in the art to put into practice them. The scope of embodiment of the present invention includes the gamut of claims and all obtainable equivalent of claims. In this article, these embodiments of the present invention can be represented individually or generally with term " invention ", this is only used to conveniently, and if in fact disclose the invention of more than one, what be not meant to automatically to limit this application ranges for any single invention or inventive concept.
Luteal phase, ovary was by the impact of luteotrophic hormone, secretes lutein, maintains the endometrium thickened. In this stage, human body is in the stage that excess of YANG the moon disappears, thus the conscience gas fire of people is just relatively vigorous, so a lot of women in this period, often there will be some agitations uncomfortable in chest, dizzy headache, the symptom such as poor of sleeping, and the premenstrual syndrome that namely it has often been said. In luteal phase, ovarian function starts to enliven, and lutein cell secretes substantial amounts of progestogen and estrogen, and endometrium can be influenced by the effect of progestogen. All there is important adjustment effect in internal various hormones.
Feature according to this stage, in certain embodiments, the described health product for women physiological period are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 11~13 parts, 18~22 parts of Semen Castaneae, 4~6 parts of Semen sojae atricolor, Quinoa 8~12 parts, prebiotics 8~12 parts, 1 part of Fructus Citri Limoniae.
In certain embodiments, the described health product for women physiological period are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 11~13 parts, 18~22 parts of Semen Castaneae, 4~6 parts of Semen sojae atricolor, Quinoa 8~12 parts, prebiotics 1 part, Semen Vitis viniferae 1~2 part.
In certain embodiments, the described health product for women physiological period are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 12 parts, 20 parts of Semen Castaneae, 5 parts of Semen sojae atricolor, Quinoa 10 parts, prebiotics 10 parts, 1 part of Fructus Citri Limoniae.
In certain embodiments, the described health product for women physiological period are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 12 parts, 20 parts of Semen Castaneae, 5 parts of Semen sojae atricolor, Quinoa 10 parts, prebiotics 10 parts, Semen Vitis viniferae 1 part.
In certain embodiments, the described health product for women physiological period are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 12 parts, 20 parts of Semen Castaneae, 5 parts of Semen sojae atricolor, Quinoa 10 parts, prebiotics 10 parts, Semen Vitis viniferae 2 parts.
In certain embodiments, each raw material is processed to powdery and makes capsule. Such as, coffee capsule is made with 1.2 grams of silk ball mycopowder, 2 grams of chest nut powders, 0.5 gram of black bean powder, 1 gram of Quinoa, 1 gram of prebiotics and 0.1 gram of Fructus Citri Limoniae; Or, make coffee capsule with 1.2 grams of silk ball mycopowder, 2 grams of chest nut powder powder, 0.4 gram of black bean powder, 1 gram of Quinoa, one gram of prebiotics and 0.2 gram of Semen Vitis viniferae.
In some preferred embodiments, described Sparassia crispa (Wulf.) Fr. is Sparassia crispa (Wulf.) Fr.-H, Sparassia crispa (Wulf.) Fr.-X or Sparassia crispa (Wulf.) Fr.-G.
Those skilled in the art are it can be readily appreciated that various raw material can also be processed to the health product of tablet, electuary or other similar tea-drinking.
Sparassia crispa (Wulf.) Fr., also cries silk ball mushroom, and Classification system is Sparassiscrispa, is non-pleat pore fungi order, silk ball Cordycepps, silk ball Pseudomonas. Because it has the activation immunocompetence of superelevation, there is the title of " the magical mushroom of illusion " in Japan. Common mushroom growth is at the back, and the irradiation that silk ball mushroom needs more than 10 hours every day, it is unique " sunlight mushroom " in the world. American-European, Japanese in great demand, expensive. The maximum feature of Sparassia crispa (Wulf.) Fr. is that every 100 grams of Sparassia crispa (Wulf.) Fr. contain beta glucan up to 43.6 grams, exceed 3~4 times than Ganoderma and Agaricus blazei Murrill containing a large amount of beta glucans. It can be said that the beta glucan contained by Sparassia crispa (Wulf.) Fr. be mushrooms. Glucosan is the polysaccharide being polymerized by glucose monomer, is divided into α type and β type, α type glucosan such as starch etc., is the main source of human body energy, does not possess biological activity. β type glucosan is a kind of bioactive substance, confirms through medical research, the several functions such as have immunomodulating, antitumor, antiinflammatory, antiviral, antioxidation, radioprotective, blood sugar lowering, blood fat reducing, protect the liver. Research also finds, it is all β (1-3) the D glucosan with β (1-6) glycosidic bond branch that great majority have the polysaccharide of anti-tumor activity. There are some researches prove, β (1-3) the D glucosan from fungus is generally of the function of tumor of suppression. Macrodex % in Sparassia crispa (Wulf.) Fr. is above β (1-3) D glucosan, has good antitumor, immunomodulating and improves the effects such as hemopoietic function. Sparassia crispa (Wulf.) Fr. contains a large amount of vitamin and mineral Sparassia crispa (Wulf.) Fr. contains vitamin C, vitamin E, and its content of vitamin E occupies Homonemeae food prostatitis, and these vitamin have antioxidation. Sparassia crispa (Wulf.) Fr., possibly together with ergosterol, can be changed into vitamin D under sunlight and ultraviolet radiation, can promote Calcium and phosphorous absorption, be conducive to skeleton to be formed, prevention children rachitis, adult's osteoporosis and osteomalacia. Sparassia crispa (Wulf.) Fr. contains at a relatively high potassium element, and the content of sodium is relatively low, and this hyperkalemia hyponatremia food has diuresis, is highly beneficial to hyperpietic. Sparassia crispa (Wulf.) Fr. contains the free radical in a large amount of antioxidant human body and biological cell oxidative damage can be caused to cause organism aging process, and destroys disease-resistant, the defence capability of body, causes cancer and cardiovascular disease chronic diseases. Nowadays, the oxidation resistance of natural food has been subjected to the most attention of people, and wherein, superoxide dismutase (SOD) can the effective free radical in purged body, it is prevented that the active oxygen injury to body, antioxidation, defying age effect.According to surveying and determination, in Sparassia crispa (Wulf.) Fr., the content of superoxide dismutase occupies first of various edible fungi.
Finding through big quantity research, Sparassia crispa (Wulf.) Fr. owing to containing a large amount of beta glucans, therefore having obvious blood nourishing function, being remarkably contributing to the conditioning of human endocrine to human body. Women takes the health product disclosed in above-described embodiment pmgravid first week (the 15th~21 day of preferred physiological period), can promoting follicular development complementing estrogen, ovulation rate kidney tonifying is good for kidney, depressed liver-energy dispersing and QI regulating, the intestines and stomach coordinating function, promotes intestinal defecation.
The new varieties of the domestic Sparassia crispa (Wulf.) Fr. cultivated, include but not limited to Sparassia crispa (Wulf.) Fr.-H, Sparassia crispa (Wulf.) Fr.-X or Sparassia crispa (Wulf.) Fr.-G etc., are suitable for each embodiment, it is preferable that Sparassia crispa (Wulf.) Fr.-H at present.
In actual applications, it is also possible to the edible fungi being considered as other replaces Sparassia crispa (Wulf.) Fr..
In certain embodiments, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: edible fungi 10~20 parts, nut 15~25 parts, Semen sojae atricolor 2~8 parts, Quinoa 5~15 parts, prebiotics 8~12 parts.
In certain embodiments, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: edible fungi 10~20 parts, nut 15~25 parts, Semen sojae atricolor 2~8 parts, Quinoa 5~15 parts, prebiotics 8~12 parts, antioxidant 1~5 part.
Wherein, described antioxidant can be Fructus Citri Limoniae, it is also possible to be Semen Vitis viniferae or the certain kind of berries. The described certain kind of berries can be blue berry can also be cranberry, it is preferable that blue berry.
Wherein, nut can be Semen Castaneae can also be Semen Juglandis, Semen Caryae Cathayensis or semen juglandis, it is preferable that Semen Castaneae; Semen sojae atricolor can be Semen Glycines, Semen sojae atricolor or Semen phaseoli radiati, it is preferable that Semen sojae atricolor; Edible fungi can be Sparassia crispa (Wulf.) Fr., it is also possible to adopt other strain according to the actual requirements, includes but not limited to Lentinus Edodes, Volvariella volvacea (Bull.Ex Franch.) Singer., Flammulina velutiper (Fr.) Sing, Hericium erinaceus (Bull. Ex Fr.) Pers., agrocyb eaegerita, bolete, Morchella esculenta (L.) Pers, cherry rivet mushroom, oronge bacterium, suillusbovinus, Russula vinosa Lindbl etc.
Semen sojae atricolor is the one of Semen sojae atricolor, is the most important phytoestrogen sources of the mankind, is that one is not only cheap but also contribute to defying age, has doctor's food food with the specific function treated. Containing nutrient substance such as more rich protein, fat, carbohydrate and carotene, vitamin B1, B2, nicotinic acid and crude fibre, calcium, phosphorus, ferrum, and containing a small amount of daidzin genistin. Both materials all have estrogen-like effects. Containing folic acid, folinic acid, riboflavin, vitamin A and carotenoid etc. in Semen sojae atricolor leaf. SEMEN COAT GLYCINES NIGRUM is containing pectin, levulic acid and various saccharides. Nature and flavor are summed up: sweet in the mouth is put down, and enters spleen channel, kidney channel. Compendium of Material Medica is said: " bean has the five colors, each treating disorders in five ZANG-organs, and only black soybean aqueous is trembled with fear, it is possible to enter kidney. Harnessing the river, relieving distension, the therapeutic method to keep the adverse QI flowing downwards, control wind heat and promoting blood circulation and detoxication, often edible Semen sojae atricolor, can all kinds of diseases and ailments not give birth to. " " it is many that Semen sojae atricolor enters kidney merit, thus can harness the river, the therapeutic method to keep the adverse QI flowing downwards of subsiding a swelling. Control wind heat and promoting blood circulation and detoxication. " pharmacological experiments shows, Semen sojae atricolor has yin nourishing QI invigorating effect, is strong nourishing food. But Semen sojae atricolor also can not polyphagia. Sun Simiao is said: " Semen sojae atricolor is eaten less and is amusing, and polyphagia damages spleen; " supplement to Thousand Golden Prescriptions is said: " food Semen sojae atricolor makes us heavy sensation of the body for a long time. " " book on Chinese herbal medicine converge with speech " says: " and Semen sojae atricolor profit and matter heavily fortified point is slided, polyphagia make us abdominal distention and under dysentery. " removing its fraud to take the profit of Semen sojae atricolor, the kind Semen sojae atricolor of ancient Chinese medicine doctor makes medicated diet, medicine bean and medicated wine, for disease preventing and treating and health care.
Quinoa (formal name used at school: Chenopodiumquinoawilld) originates in mountain area, South America Andean, it it is the main conventional food printing and adding aborigines, there is the 5000-7000 plantation history of many years, owing to it has abundant, the comprehensive nutritive value of uniqueness, having brought up print and added nationality, ancient times, Inca was referred to as " mother of grain ".Quinoa seed color mainly has several colors white, black, red, and nutritional labeling is more or less the same, and wherein white mouthfeel is best, and a little seed of mouthfeel relative mistake black, red is also less. Quinoa is used for the space food of spaceman in the 1980's by NASA. FAO (Food and Agriculture Organization of the United Nation) thinks that Quinoa is the food that unique a kind of solitary plant can substantially meet human body basic nutrition demand, and formal recommendation Quinoa is the perfect wholefood of the optimum mankind. The United Nations was declared as international Quinoa year by 2013, to promote human nutrition healthy and food safety, it is achieved MDGs.
Prebiotics (Prebiotics) is the composition of a kind of chosen property fermentation, produces special change, flora in tissue, activation digestive system, host health is useful. Prebiotic matter is a kind of dietary supplement, and it can pass through the growth optionally stimulating the antibacterial in a kind of or minority kind bacterium colony and activity, and host produces wholesome effect, thus improving host health. Prebiotic matter generally belongs to saccharide (such as oligosaccharide), but its definition does not get rid of non-carbohydrate content. Successful prebiotics should be when by upper digestive tract, and major part is not digested and can be fermented by intestinal microbial population. The most important thing is that it simply stimulates the growth of profitable strain, rather than have the noxious bacteria of potential pathogenic or corrupt activity.
The embodiment of invention described herein is illustrative of, and it is conceivable that many corrections, change and adjustment can reach the result being substantially equal, all these are intended to be included in the spirit and scope of the present invention. Additionally, the purpose of above-mentioned summary is to make the general public, particularly it is unfamiliar with this area scientist of patent or law term or wording, engineer and practitioner, by essence and the characteristic that can understand present techniques content rapidly of skimming.
Claims (10)
1. the health product that a women physiological period is taken, it is characterised in that be made up of following raw materials by weight portion ratio:
Edible fungi 10~20 parts;
Nut 15~25 parts;
Semen sojae atricolor 2~8 parts;
Quinoa 5~15 parts;
Prebiotics 8~12 parts.
2. the health product that a women physiological period is taken, it is characterised in that be made up of following raw materials by weight portion ratio:
Edible fungi 10~20 parts;
Nut 15~25 parts;
Semen sojae atricolor 2~8 parts;
Quinoa 5~15 parts;
Prebiotics 8~12 parts;
Antioxidant 1~5 part.
3. health product as claimed in claim 2, it is characterised in that described antioxidant is Fructus Citri Limoniae, Semen Vitis viniferae or the certain kind of berries.
4. the health product as described in claim 1,2 or 3, it is characterised in that described edible fungi is Sparassia crispa (Wulf.) Fr.; Described nut is Semen Castaneae, Semen Caryae Cathayensis, Semen Juglandis or Semen Juglandis; Described Semen sojae atricolor is Semen sojae atricolor or Semen Glycines.
5. health product as claimed in claim 4, it is characterised in that described Sparassia crispa (Wulf.) Fr. is Sparassia crispa (Wulf.) Fr.-H, Sparassia crispa (Wulf.) Fr.-X or Sparassia crispa (Wulf.) Fr.-G; The described certain kind of berries is blue berry or cranberry.
6. the health product for women physiological period, it is characterised in that be made up of following raw materials by weight portion ratio:
Sparassia crispa (Wulf.) Fr. 11~13 parts;
18~22 parts of Semen Castaneae;
4~6 parts of Semen sojae atricolor;
Quinoa 8~12 parts;
Prebiotics 8~12 parts;
1 part of Fructus Citri Limoniae.
7. the health product for women physiological period, it is characterised in that be made up of following raw materials by weight portion ratio:
Sparassia crispa (Wulf.) Fr. 11~13 parts;
18~22 parts of Semen Castaneae;
4~6 parts of Semen sojae atricolor;
Quinoa 8~12 parts;
Prebiotics 8~12 parts;
Semen Vitis viniferae 1~2 part.
8. health product as claimed in claims 6 or 7, it is characterised in that the parts by weight of described Sparassia crispa (Wulf.) Fr. are 12 parts; The parts by weight of described Semen Castaneae are 20 parts; The parts by weight of described Quinoa are 10 parts; The parts by weight of described prebiotics are 10 parts.
9. the health product as described in any one of claim 1 to 8, it is characterised in that each raw material is processed to powdery and makes capsule, tablet or electuary.
10. the health product as described in any one of claim 1 to 8, it is characterised in that described health product women took at pmgravid first week.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610073202.8A CN105661486A (en) | 2016-02-02 | 2016-02-02 | Healthcare product for women in menstrual period |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610073202.8A CN105661486A (en) | 2016-02-02 | 2016-02-02 | Healthcare product for women in menstrual period |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105661486A true CN105661486A (en) | 2016-06-15 |
Family
ID=56303438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610073202.8A Pending CN105661486A (en) | 2016-02-02 | 2016-02-02 | Healthcare product for women in menstrual period |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105661486A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106901345A (en) * | 2017-03-22 | 2017-06-30 | 山东木婉清食品有限公司 | A kind of effective anti-aging, the Sparassis crispa meal replacement powder for removing interior free yl |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103815404A (en) * | 2014-03-10 | 2014-05-28 | 张德敏 | Nutritional food according with theory of yin-yang balance of five elements and preparation method of nutritional food |
CN105076970A (en) * | 2015-08-19 | 2015-11-25 | 胡玉 | Diet health-maintaining porridge for women during physiological period |
-
2016
- 2016-02-02 CN CN201610073202.8A patent/CN105661486A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103815404A (en) * | 2014-03-10 | 2014-05-28 | 张德敏 | Nutritional food according with theory of yin-yang balance of five elements and preparation method of nutritional food |
CN105076970A (en) * | 2015-08-19 | 2015-11-25 | 胡玉 | Diet health-maintaining porridge for women during physiological period |
Non-Patent Citations (1)
Title |
---|
甘智荣: "《家常饮食巧用心 脾胃虚弱不发愁》", 31 July 2015, 吉林科学技术出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106901345A (en) * | 2017-03-22 | 2017-06-30 | 山东木婉清食品有限公司 | A kind of effective anti-aging, the Sparassis crispa meal replacement powder for removing interior free yl |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (en) | Health-care food for preventing diabetes | |
CN103005281B (en) | High-nutrient healthcare rice and preparation method thereof | |
CN102813120B (en) | Anti-cancer sea cucumber sugar-reducing flour and preparation method thereof | |
CN102630858B (en) | Compound pig feed containing Chinese herbal medicine | |
CN102144748A (en) | Five-color flour food with functions of excreting toxins, protecting liver and maintaining beauty | |
CN107114663A (en) | A kind of fruits and vegetables nourishing the stomach ground rice and preparation method thereof | |
CN106213501A (en) | A kind of nutrition soup and preparation method thereof | |
CN105341668A (en) | Health-preserving quinoa porridge | |
CN104643080A (en) | Combined formula of three-day food exchange body shaping product and eating method | |
CN107048164A (en) | A kind of low sugar rice cake | |
CN105233100A (en) | Drink for treating diabetes and preparation method thereof | |
CN111227260A (en) | Composition rich in dietary fiber, diet meal bag solid beverage and preparation method thereof | |
CN108887564A (en) | A kind of selenoprotein coarse cereal powder formula and preparation method thereof | |
CN104970421A (en) | Longan and donkey-hide gelatin powder composite solid drink | |
CN105384562A (en) | Pleurotus geesteranus medium | |
CN111000252A (en) | Fat-reducing and nutrition-balancing meal replacement food and preparation method thereof | |
CN104824674A (en) | Nutrient health-care food for preventing and treating alopecia | |
CN107223846A (en) | A kind of suitable middle-aged and old grain healthcare powder | |
CN105831658A (en) | Sparassis crispa health caring jelly | |
CN105249440A (en) | Donkey-hide gelatin cake | |
CN101103816B (en) | Sea-buckthorn nutrient food additive and flour composition containing thereof | |
CN105661486A (en) | Healthcare product for women in menstrual period | |
KR20200023053A (en) | Powder type multiple food supplement comprising beta glucan powder, chitosan powder, acerola extract powder, ganoderma lucidum fruit body powder, grifola frondosa powder, lentinus edodes mycelium powder, lycium chinense powder, aloe powder, angelica gigas extract powder and ginseng extract powder | |
CN101797049B (en) | Nutrient eight-treasure soup formula and preparation process thereof | |
KR20050115836A (en) | Balanced food based on various nutritional ingredients such as brown rice embryo, wheat germ, germinated brown rice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160615 |
|
RJ01 | Rejection of invention patent application after publication |